[{"Assets_0_Q2_USD":149641000.0,"CommonStockSharesOutstanding_0_Q2_shares":40027916.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-52422000.0,"NetIncomeLoss_1_Q2_USD":-22960000.0,"NetIncomeLoss_2_Q2_USD":-44920000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":39818162.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":39685954.0,"StockholdersEquity_0_Q2_USD":99545000.0,"Ticker":"CARA","CIK":"1346830","name":"CARA THERAPEUTICS, INC.","OfficialName":"Cara Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"703167627.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]